Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

212017-07

NOTICE OF THE 2017 FIRST EXTRAORDINARY GENERAL MEETING
212017-07

PROPOSED FURTHER CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING
202017-07

(1) PROPOSED A SHARE OFFERING AND AMENDMENTS TO THE (DRAFT) ARTICLES OF ASSOCIATION;(2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION;AND(3) RESIGNATION OF NON-EXECUTIVE DIRECTOR
192017-07

RESIGNATION OF EXECUTIVE DIRECTOR
192017-07

List of directors and their roles and functions
122017-07

DISCLOSEABLE TRANSACTION IN RELATION TO ACQUISITION OF PROPERTIES
032017-07

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2017
262017-06

ENVIRONMENTAL,SOCIAL AND GOVERNANCE REPORT
132017-06

VOLUNTARY ANNOUNCEMENT LETTER OF INTENT IN RELATION TO POSSIBLE ACQUISITION OF PROPERTY
112017-06

ESTABLISHING THE STRATEGIC DEVELOPMENT COMMITTEE AND CHANGE OF THE CHAIRMAN OF THE NOMINATION COMMITTEE
112017-06

(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 10 JUNE 2017;(2) DISTRIBUTION OF 2016 FINAL DIVIDEND;(3) CHANGE OF AUDITORS;AND(4) APPOINTMENT OF NON-EXECUTIVE DIRECTOR
022017-06

ANNOUNCEMENT PROPOSED A-SHARE ISSUE

27 28 29 30 31

The Enterprise OA